{
  "abstract": "We read with interest the multicohort study by Luo et al evaluating the China-CLIF framework for acute-on-chronic liver failure (ACLF) across diverse aetiologies.1 The authors demonstrate that China-CLIF criteria and COSSH-ACLF II score improve short-term mortality prediction compared with traditional models. These findings naturally raise an important policy question: should China-CLIF-based classifications influence model for end-stage liver disease (MELD)-driven liver transplant priority?",
  "authors": [
    {
      "affiliations": [
        "Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"
      ],
      "name": "Kang He"
    },
    {
      "affiliations": [
        "Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"
      ],
      "name": "Chengpeng Zhong"
    },
    {
      "affiliations": [
        "Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"
      ],
      "name": "Qiang Xia"
    }
  ],
  "title": "Should the China-CLIF framework influence model for end-stage liver disease-based transplant priority in acute-on-chronic liver failure?",
  "uid": "c3d1af5b-3c84-5010-b32e-8873d504608c"
}